Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To <12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial von Chehade, Mirna, Dellon, Evan, Spergel, Jonathan, Rothenberg, Marc, Pesek, Robert, Collins, Margaret, Hirano, Ikuo, Liu, Ruiqi, Laws, Elizabeth, Mortensen, Eric, Martincova, Renata, Maloney, Jennifer, McCann, Eilish, Kosloski, Matthew, Hamilton, Jennifer, Samuely, Carin, Glotfelty, Lila, Shabbir, Arsalan

Volltext

Sa1255 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN CHILDREN AGED 1 TO &lt;12 YEARS WITH EOSINOPHILIC ESOPHAGITIS (EOE): 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL von Chehade, Mirna, Dellon, Evan S., Spergel, Jonathan, Rothenberg, Marc E., Pesek, Robert, Collins, Margaret H., Hirano, Ikuo, Liu, Ruiqi, Laws, Elizabeth, Mortensen, Eric R., Abdulai, Raolat M., Maloney, Jennifer, McCann, Eilish, Kosloski, Matthew, Hamilton, Jennifer D., Samuely, Carin, Glotfelty, Lila, Shabbir, Arsalan

Volltext

Sa1255 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN CHILDREN AGED 1 TO <12 YEARS WITH EOSINOPHILIC ESOPHAGITIS (EOE): 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL von Chehade, Mirna, Dellon, Evan S., Spergel, Jonathan, Rothenberg, Marc E., Pesek, Robert, Collins, Margaret H., Hirano, Ikuo, Liu, Ruiqi, Laws, Elizabeth, Mortensen, Eric R., Abdulai, Raolat M., Maloney, Jennifer, McCann, Eilish, Kosloski, Matthew, Hamilton, Jennifer D., Samuely, Carin, Glotfelty, Lila, Shabbir, Arsalan

Volltext

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age von Chehade, Mirna, Dellon, Evan S., Spergel, Jonathan M., Collins, Margaret H., Rothenberg, Marc E., Pesek, Robert D., Hirano, Ikuo, Liu, Ruiqi, Laws, Elizabeth, Mortensen, Eric, Martincova, Renata, Shabbir, Arsalan, McCann, Eilish, Kamal, Mohamed A., Kosloski, Matthew P., Hamilton, Jennifer D., Samuely, Carin, Lim, Wei Keat, Wipperman, Matthew F., Farrell, Annamaria, Patel, Naimish, Yancopoulos, George D., Glotfelty, Lila, Maloney, Jennifer

Volltext